JPH0325181B2 - - Google Patents

Info

Publication number
JPH0325181B2
JPH0325181B2 JP62266204A JP26620487A JPH0325181B2 JP H0325181 B2 JPH0325181 B2 JP H0325181B2 JP 62266204 A JP62266204 A JP 62266204A JP 26620487 A JP26620487 A JP 26620487A JP H0325181 B2 JPH0325181 B2 JP H0325181B2
Authority
JP
Japan
Prior art keywords
bone
hydroxyapatite
parts
weight
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62266204A
Other languages
Japanese (ja)
Other versions
JPS63294864A (en
Inventor
Susumu Takada
Shoichi Wakabayashi
Hiroyasu Noma
Tatsuya Wakatsuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TDK Corp
Original Assignee
TDK Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TDK Corp filed Critical TDK Corp
Priority to JP62266204A priority Critical patent/JPS63294864A/en
Publication of JPS63294864A publication Critical patent/JPS63294864A/en
Publication of JPH0325181B2 publication Critical patent/JPH0325181B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Dental Preparations (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Materials For Medical Uses (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、歯科、口腔外科、整整外科などの治
療用として好適な人工骨材料、さらに詳しくいえ
ば、生体の骨腫瘍その他によつて生じる骨欠損部
や空隙部に充てんして当該個所の新生骨の形成を
促進し、それ自体が生体の骨組識と一体化しうる
生体親和性に優れ、顆粒状の多孔質水酸アパタイ
ト焼結体から成る人工骨材料の製造方法にに関す
るものである。
[Detailed Description of the Invention] [Field of Industrial Application] The present invention is directed to artificial bone materials suitable for use in dentistry, oral surgery, orthopedic surgery, etc. Made from granular porous sintered hydroxyapatite, which has excellent biocompatibility and can be filled into bone defects and voids to promote the formation of new bone in the area, and can be integrated with the bone structure of the living body. The present invention relates to a method of manufacturing an artificial bone material comprising:

従来の技術 従来、歯科治療においては、抜歯後歯槽骨が吸
収されて、入れ歯などの固定が不十分になるとい
う問題があり、また口腔外科や整形外科治療にお
いては、例えば交通事故や骨腫瘍などの疾患によ
り、失われた骨を補綴するために、患者自身の他
の部分の骨、すなわち自家骨の移植などが試みら
れているが、損傷個所以外の骨組識を切除するこ
とから、患者の肉体的及び心理的負担が極めて大
きいという問題や、広範な骨欠損部を充てんする
には十分な量の自家骨を採取できないという問題
などがあつた。
Conventional technology Conventionally, in dental treatment, there has been a problem in which the alveolar bone is resorbed after tooth extraction, making it impossible to secure dentures etc. In addition, in oral surgery and orthopedic treatment, there has been a problem in cases such as traffic accidents, bone tumors, etc. In order to replace the bone lost due to this disease, attempts have been made to transplant bone from other parts of the patient, i.e., autologous bone, but since bone tissue other than the damaged area is removed, the patient's There were problems such as the extremely heavy physical and psychological burden and the inability to collect enough autologous bone to fill in extensive bone defects.

このような事情の下で、近年人工歯根や人工骨
材に関する研究が盛んに行われるようになつてき
た。これらの人工骨の材料については、生体内に
埋入する際にして、毒性がなく安全で、かなりの
機械的強度を有し、かつ生体組識と結合しやすい
ものを選ぶことが必要とされ、さらに生体内で自
然に消失して新生骨と置換されるものが好ましい
とされている。
Under these circumstances, research on artificial tooth roots and artificial aggregates has been actively conducted in recent years. When implanting these artificial bones into a living body, it is necessary to select materials that are non-toxic, safe, have considerable mechanical strength, and are easily bonded to living tissue. Furthermore, it is preferable to use a material that naturally disappears in the living body and is replaced by new bone.

このような要件を満たす材料として、近年、リ
ン酸三カルシウム、水酸アパタイト又は特殊なア
パタイト型結晶構造リン酸カルシウム化合物の焼
結体が注目されており、これらを用いた人工骨、
人工関節、人工歯根などの研究が盛んに行われて
いる。
In recent years, sintered bodies of tricalcium phosphate, hydroxyapatite, or calcium phosphate compounds with a special apatite-type crystal structure have attracted attention as materials that meet these requirements, and artificial bones using these materials,
Research into artificial joints, artificial tooth roots, etc. is actively being conducted.

ところで、人工骨や人工歯根を体内に埋入した
ときに、生体組識と結合しやすくするには、これ
を多孔質のものとして生体組識が細孔に入り込
み、これを固定しうるようにすることが必要であ
り、この目的を達成するために、例えば孔径0.03
〜1.2mm程度の気孔を有する多孔質リン酸カルシ
ウム系焼結体を用いることが提案されている(特
開昭56−149389号公報、開昭57−7856号公報)。
By the way, when an artificial bone or tooth root is implanted in the body, in order to make it easier to bond with the living tissue, it is necessary to make it porous so that the living tissue can enter the pores and fix it. and to achieve this purpose, e.g. pore size 0.03
It has been proposed to use a porous calcium phosphate sintered body having pores of about 1.2 mm (Japanese Patent Application Laid-open Nos. 149389-1989 and 7856-1987).

しかしながら、この多孔質リン酸カルシウム系
焼結体から成る人工骨材は、硬くてもろいなど、
機械的強度が十分でないという欠点があり、また
素材がち密質であるため、生体内における吸収や
新生骨の置換などに関して必ずしも満足しうるも
のではない。
However, this artificial aggregate made of porous calcium phosphate sintered material is hard and brittle.
It has the drawback of not having sufficient mechanical strength, and since the material is dense, it is not necessarily satisfactory in terms of in-vivo absorption and replacement of new bone.

さらに、結晶粒径が50Å〜10μmのアパタイト
型結晶構造リン酸カルシウム化合物の粉粒体に生
理食塩水などを加えて流動状態又は可塑状態とし
た骨欠損部充てん材が提案されている(特開昭56
−54841号公報)。しかしながら、この充てん材に
おいては、使用するリン酸カルシウム化合物が微
粉状であるため、このものを骨欠損部に充てんし
て、縫合する際に、該微粉状物が皮膚創傷面に付
着して縫合が困難であるという欠点がある。
Furthermore, a bone defect filling material has been proposed in which a powder of an apatite-type crystal structure calcium phosphate compound with a crystal grain size of 50 Å to 10 μm is made into a fluid or plastic state by adding physiological saline etc.
−54841). However, since the calcium phosphate compound used in this filling material is in the form of a fine powder, when this material is filled into a bone defect and sutured, the fine powder adheres to the surface of the skin wound, making suturing difficult. It has the disadvantage of being.

発明が解決しようとする問題点 本発明の目的は、このような欠点を改良し、骨
欠損部や空隙部に充てんして、当該個所の新生骨
の形成を促進し、それ自体が骨組識と一体化しう
る生体親和性に優れたものであり、その上手術の
際に何ら弊害を伴わないような人工骨材料を得る
ための製造方法を提供することにある。
Problems to be Solved by the Invention The purpose of the present invention is to improve the above-mentioned drawbacks, to fill bone defects and voids, to promote the formation of new bone in the areas concerned, and to provide bone tissue itself. It is an object of the present invention to provide a manufacturing method for obtaining an artificial bone material that can be integrated into one body, has excellent biocompatibility, and does not cause any adverse effects during surgery.

問題点を解決するための手段 本発明者らは、水酸アパタイトを原料として、
骨欠損部や空隙部に充てんして用いたとき、なん
ら副作用を伴わず、順調に骨組識と一体化しうる
人工骨材料を得るために鋭意研究を重ねた結果、
水酸アパタイトと結晶セルロースとの混合物を造
粒し、所定の条件下で焼成することによりその目
的を達成うることを見出し、この知見に基づいて
本発明をなすに至つた。
Means for Solving the Problems The present inventors have developed a method using hydroxyapatite as a raw material.
As a result of intensive research to obtain an artificial bone material that can be smoothly integrated into bone tissue without causing any side effects when used to fill bone defects or voids,
The inventors have discovered that the objective can be achieved by granulating a mixture of hydroxyapatite and crystalline cellulose and firing it under predetermined conditions, and based on this knowledge, the present invention has been accomplished.

すなわち、本発明は、平均粒径0.1〜10μmの水
酸アパタイト粉末100重量部と、平均粒径10〜
100μmの結晶セルロース2〜100重量部との混合
物を粒径0.1〜3.0mmの顆粒に造粒したのち、900
〜1400℃で焼成することを特徴とする人工骨材料
の製造方法を提供するのである。
That is, the present invention provides 100 parts by weight of hydroxyapatite powder with an average particle size of 0.1 to 10 μm and 100 parts by weight of hydroxyapatite powder with an average particle size of 10 to 10 μm.
After granulating a mixture with 2 to 100 parts by weight of 100 μm crystalline cellulose into granules with a particle size of 0.1 to 3.0 mm,
The present invention provides a method for producing an artificial bone material characterized by firing at a temperature of ~1400°C.

本発明で用いる水酸アパタイトは、乾式法又は
湿式法による合成アパタイトでもよいし、各種脊
椎動物の骨、歯から回収された生体アパタイトで
もよい。この原料の水酸アパタイトはできるだけ
微粉状に粉砕したものを用いるのが望ましいが、
粉砕機、分級機などの装置的制限や取扱い上の問
題もあるため、平均粒径0.1〜10μm、好ましくは
0.5〜7μmの範囲のものが用いられる。
The hydroxyapatite used in the present invention may be apatite synthesized by a dry method or a wet method, or may be a living body apatite recovered from bones and teeth of various vertebrates. It is desirable to use this raw material, hydroxyapatite, that has been ground into as fine a powder as possible.
Due to equipment limitations such as crushers and classifiers and handling problems, the average particle size is 0.1 to 10 μm, preferably
A thickness in the range of 0.5 to 7 μm is used.

次に本発明で用いる結晶セルロースは、セルロ
ースを鉱酸により加水分解して、非結晶部分を洗
浄、除去したのち、摩砕、精製、乾燥して得られ
る微粉末で、水酸アパタイトを焼結する際に所望
の孔径をもつ連続気孔を形成させるために配合す
るものである。本発明においては、孔径10〜
100μmの連続気孔を有し、気孔率20〜50%の多
孔質顆粒体を得るために、平均粒径10〜100μm
のものを、水酸アパタイト粉末100重量部当り25
〜100重量部の割合で配合することが必要である。
平均粒径が10μm未満のものを用いた場合には得
られる多孔質顆粒体の連続気孔の孔径が小さくな
りすぎて、生体内に充てん使用した際、破骨細胞
が侵入しにくくなる結果、新生骨との置換が遅く
なり、また、この平均粒径が100μmよりも大き
いものを用いると、得られた多孔質顆粒体は
100μmよりも大きい孔径の連続気孔をもつもの
となるが、このように大きい孔径の連続気孔の中
では線維茅細胞が優先的に成長し、骨茅細胞の成
長を阻害する原因となる。
Next, the crystalline cellulose used in the present invention is a fine powder obtained by hydrolyzing cellulose with mineral acid, washing and removing the amorphous portion, then grinding, refining, and drying, and sintering hydroxyapatite. It is blended in order to form continuous pores with a desired pore size during the process. In the present invention, the pore size is 10~
In order to obtain porous granules with continuous pores of 100 μm and a porosity of 20 to 50%, the average particle size is 10 to 100 μm.
25 per 100 parts by weight of hydroxyapatite powder
It is necessary to mix it in a proportion of ~100 parts by weight.
When using particles with an average particle size of less than 10 μm, the pore size of the continuous pores of the resulting porous granules becomes too small, making it difficult for osteoclasts to invade when used as a filler in a living body, resulting in new growth. Replacement with bone becomes slow, and if particles with an average particle size larger than 100 μm are used, the resulting porous granules
It has continuous pores with a pore size larger than 100 μm, but fibrous cells grow preferentially in the continuous pores with such a large pore size, which causes inhibition of the growth of bone lining cells.

そして、これまでリン酸カルシウム系多孔質顆
粒体の製造には、メチルメタクリレート、ポリプ
ロピレン、ポリスチレンのようなプラスチツクが
気孔形成用昇華性物質として用いられたが、これ
らの物質は焼結に際し、完全に除去されないまま
で使用すると、人体に悪影響を与えるのに対し、
本発明で用いる結晶セルロースは、人体に無害
で、かびや細菌などの微生物に汚染されず、また
化学的に不活性なので、たとえ生体内に取り入れ
られても全く無害である。
Until now, plastics such as methyl methacrylate, polypropylene, and polystyrene have been used as sublimable substances to form pores in the production of calcium phosphate-based porous granules, but these substances are not completely removed during sintering. If used as is, it will have a negative effect on the human body,
The crystalline cellulose used in the present invention is harmless to the human body, is not contaminated by microorganisms such as mold or bacteria, and is chemically inert, so it is completely harmless even if taken into the body.

また、この結晶セルロースは前記したように、
水酸アパタイト100重量部当り25〜100重量部の割
合で用いるとが必要である。これよりも少ない量
では得られた人工骨材料の気孔率が20%未満とな
り十分な連続気孔が形成されないし、これりも多
い量では気孔率が50%を超え、見掛け密度や機械
的強度が著しく低下する。この機械的強度の点か
らいえば、水酸アパタイト100重量部当り30〜70
重量部、に40〜60重量部の範囲が好ましい。
In addition, as mentioned above, this crystalline cellulose is
It is necessary to use it in a proportion of 25 to 100 parts by weight per 100 parts by weight of hydroxyapatite. If the amount is less than this, the porosity of the artificial bone material obtained will be less than 20%, and sufficient continuous pores will not be formed.If the amount is too large, the porosity will exceed 50%, and the apparent density and mechanical strength will be Significantly decreased. In terms of mechanical strength, 30 to 70 parts per 100 parts by weight of hydroxyapatite
The preferred range is 40 to 60 parts by weight.

水酸アパタイト粉末と結晶セルロースとの混合
は、両者が一に混合しうるような手段であればど
のような手段を用いてよい。例えば水酸アパタイ
ト粉末と結晶セルロースをそのまま適当な混合機
を用いて混合してもよいし、また水酸アパタイト
粉末を、あらかじめ粒径20〜200μm顆粒状に成
形し、これと結晶セルロースとを混合してもよ
い。さらに、結晶セルロースの表面を水その他の
溶媒で湿潤させ、これに水酸アパタイトを均一に
付着させる方法をとることもできる。
Any means may be used to mix the hydroxyapatite powder and crystalline cellulose as long as they can be mixed together. For example, hydroxyapatite powder and crystalline cellulose may be mixed as is using an appropriate mixer, or hydroxyapatite powder may be formed into granules with a particle size of 20 to 200 μm in advance and mixed with crystalline cellulose. You may. Furthermore, it is also possible to wet the surface of crystalline cellulose with water or other solvent, and then uniformly adhere hydroxyapatite thereto.

本発明においては、このようにして調製した水
酸アパタイト粉末と結晶セルロースとの混合物
を、粒径0.1〜3.0mmの顆粒に造粒することが必要
である。この造粒に際しては、必要に応じてポリ
ビニルアルコールのようなバインダーを添加する
ことができる。
In the present invention, it is necessary to granulate the thus prepared mixture of hydroxyapatite powder and crystalline cellulose into granules with a particle size of 0.1 to 3.0 mm. During this granulation, a binder such as polyvinyl alcohol can be added if necessary.

この粒径が0.1mm未満では、骨欠損部などに充
てんして縫合する際に、このものが皮膚創傷面に
付着して縫合が困難になり、また2mmを超える
と、このものに生理食塩水を加えた場合、均一な
スラリーが形成されず、手術の際の取り扱いが困
難となる。
If the particle size is less than 0.1 mm, it will adhere to the surface of the skin wound and suturing will be difficult when filling bone defects etc., and if it exceeds 2 mm, it will be difficult to suture with saline. If this is added, a uniform slurry will not be formed, making handling during surgery difficult.

このようにして造粒された顆粒は、次いで徐々
に900〜1400℃の温度まで加熱し、この温度で焼
成する。焼成時間は、通常0.5〜3時間である。
なお、焼成は加圧せずに行うこともできるが、例
えばホツトプレスを用いて300〜1000Kg/cm2の圧
力を加えて行うのが好ましい。
The granules thus granulated are then gradually heated to a temperature of 900-1400°C and calcined at this temperature. Firing time is usually 0.5 to 3 hours.
Although the firing can be carried out without applying pressure, it is preferable to carry out the firing by applying a pressure of 300 to 1000 kg/cm 2 using a hot press, for example.

このようにて得られた顆粒状の多孔質水酸アパ
タイト焼結体は、例えば生理的食塩水を加えて均
一なスラリー状のものとして用いることができ
る。この際の水酸アパタイト焼結体と生理食塩水
との割合は、通常重量基準で2:1ないし1:2
の範囲で選ばれる。
The granular porous hydroxyapatite sintered body thus obtained can be used as a uniform slurry by adding physiological saline, for example. At this time, the ratio of the sintered hydroxyapatite and physiological saline is usually 2:1 to 1:2 on a weight basis.
selected within the range.

発明の効果 本発明により得られる人工骨材料は、水酸アパ
タイトと、人体に対して無害な結晶セルロースを
用いたものであるから、長期間にわたつて人体中
に充てんしてもなんら影響を生じるおれはない。
また、孔径10〜100μmの連続気孔を有し、かつ
気孔率が20〜50%である粒径0.1〜2.0mmの顆粒状
多孔質アパタイト焼結体を用いているため、骨欠
損部や空隙部に充てんした場合、生体組識と結合
しやすく、また生体内において破骨細胞(50〜
100μm)及び骨茅細胞(20〜30μm)が気孔内に
入り、その作用を受けて、新生骨の増殖吸収が正
常に行われ、水酸アパタイトと新生骨と強固な接
合が実現されるという特徴を示す。また縫合の際
に、皮膚創傷面に付着することがないので、手術
を容易に行うことができる。したがつて、この人
工骨材料は歯科、口腔外科、整形外科などの治療
に好適である。
Effects of the Invention Since the artificial bone material obtained by the present invention uses hydroxyapatite and crystalline cellulose, which is harmless to the human body, it will not cause any adverse effects even if it is filled into the human body for a long period of time. I'm not there.
In addition, since it uses a granular porous apatite sintered body with a grain size of 0.1 to 2.0 mm, which has continuous pores with a pore diameter of 10 to 100 μm and a porosity of 20 to 50%, it can be used to remove bone defects and voids. When filled with Osteoclast cells (50~
100 μm) and bone mole cells (20 to 30 μm) enter the pores, and under their influence, the growth and absorption of new bone occurs normally, and a strong bond between hydroxyapatite and new bone is realized. shows. Furthermore, since it does not adhere to the skin wound surface during suturing, surgery can be performed easily. Therefore, this artificial bone material is suitable for treatments such as dentistry, oral surgery, and orthopedics.

実施例 次に実施例によつて本発明をさらに詳細に説明
する。
EXAMPLES Next, the present invention will be explained in more detail with reference to Examples.

実施例 湿式法で合成した水酸アパタイトを900℃にお
いて1時間仮焼したのち、ボールミルを用いて平
均粒径0.5μmに粉砕した。次いでこのもの100重
量部にポリビニルアルコール2重量部及び平均粒
径50μmの結晶セルロース粉末50重量部を加え、
混合したのち、これを粒径0.5〜3.0mmの顆粒に造
粒し、毎時100℃の昇温速度で1350℃まで加熱し、
この温度において1時間焼結して、平均孔径50μ
mの連続気孔を有する、気孔率26%の水酸アパタ
イトの顆粒状焼結体を得た。
Example Hydroxyapatite synthesized by a wet method was calcined at 900° C. for 1 hour, and then ground to an average particle size of 0.5 μm using a ball mill. Next, 2 parts by weight of polyvinyl alcohol and 50 parts by weight of crystalline cellulose powder with an average particle size of 50 μm were added to 100 parts by weight of this material.
After mixing, this was granulated into granules with a particle size of 0.5 to 3.0 mm, and heated to 1350°C at a heating rate of 100°C per hour.
After sintering at this temperature for 1 hour, the average pore size was 50μ.
A granular sintered body of hydroxyapatite with a porosity of 26% and having continuous pores of m was obtained.

このようにして得られた顆粒状の多孔質水酸ア
パタイト焼結体100重量部に生理食塩水100重量部
を加えスラリー状となして、本発明の人工骨材料
を得た。
100 parts by weight of physiological saline was added to 100 parts by weight of the granular porous hydroxyapatite sintered body thus obtained to form a slurry, thereby obtaining the artificial bone material of the present invention.

比較例 実施例と同様にして、粒径5〜10μmの粉末状
の多孔質水酸アパタイト焼結物(実施例における
顆粒に造粒する前のもの)を作成し、このもの
100重量部に生理食塩水100重量部を加えスラリー
状となして、人工骨材料を得た。
Comparative Example A porous hydroxyapatite sintered powder with a particle size of 5 to 10 μm (before granulation in the example) was prepared in the same manner as in the example.
An artificial bone material was obtained by adding 100 parts by weight of physiological saline to 100 parts by weight to form a slurry.

適用例 実施例で得た人工骨材料を、ウサギの下顎骨内
の骨欠損部に充てんする手術を行つたところ、皮
膚創傷面への付着は全く認められず、縫合は極め
て容易であり、創傷面のし開、反応性炎症もなく
治瘉した。
Application example When a surgery was performed to fill the bone defect in the mandible of a rabbit with the artificial bone material obtained in the example, no adhesion to the skin wound surface was observed, suturing was extremely easy, and the wound The tumor was cured without surface incision or reactive inflammation.

この手術後の骨組識について12週後及び24週後
に顕微鏡で観察したところ、以下の知見を得た。
When the bone structure after this surgery was observed under a microscope 12 and 24 weeks later, the following findings were obtained.

12週後において、水酸アパタイト顆粒の間隙に
形成された新生骨組識は、厚さと密度を増すとと
もに層板構造もはつきり認められる。また、一部
には破骨細胞が出現し、水酸アパタイト顆粒に接
して形成された層板構造の新生骨を吸収している
状態も認められ、活発な骨改造機転の進行がうか
がわれる。水酸アパタイト顆粒内部の気孔には、
骨茅細胞が侵入し気孔壁に沿つて新生骨の形成が
認められる。該植部位周辺の識にも、反応炎症
は、全く見られず良好な治瘉過程を示している。
After 12 weeks, the new bone structure formed between the hydroxyapatite granules increases in thickness and density, and a lamellar structure is clearly observed. In addition, osteoclasts appeared in some areas and were observed to be resorbing new bone with a lamellar structure formed in contact with hydroxyapatite granules, indicating the active progress of bone remodeling. . In the pores inside the hydroxyapatite granules,
Bone algae cells invade and new bone formation is observed along the pore walls. No reaction inflammation was observed in the surrounding area of the transplant site, indicating a good healing process.

24週後において、水酸アパタイト顆粒の間隙に
形成された新生骨はいつそう厚く、ち密になり、
新生骨の間に水酸アパタイト顆粒が散在する状態
になつている。水酸アパタイト顆粒内部の気孔
は、新生骨で埋めつくされ、一部には破骨細胞様
多核巨細胞による吸収も認められる。また、新生
骨の骨小腔の配列が規則的になり、層板は顎骨の
長軸方向に配列しているのが分かる。さらに、拡
大したハバース管や骨髄の形成が認められ、水酸
アパタイト顆粒、骨組識と強固なマトリツクスを
組み、完全な骨生治瘉が得られた。
After 24 weeks, the new bone formed between the hydroxyapatite granules becomes thicker and denser.
Hydroxyapatite granules are scattered between the new bones. The pores inside the hydroxyapatite granules are filled with new bone, and some are also resorbed by osteoclast-like multinucleated giant cells. It can also be seen that the lacunae of the new bone are arranged in a regular manner, and the lamellae are arranged in the longitudinal direction of the jawbone. Furthermore, enlarged Haversian canals and bone marrow formation were observed, forming a strong matrix with hydroxyapatite granules and bone tissue, resulting in complete bone regeneration.

比較適用例 比較例で得た人工骨材料を適用例と同様にして
ウサギの下顎骨内の骨欠損部に充てんする手術を
行つたところ、材料が皮膚創傷面に付着して縫合
閉鎖が困難であつた。また、縫合後も、創傷面の
し開と組識の反応性炎症がめられ、治瘉の遅延が
みられた。
Comparative application example When a surgery was performed in which the artificial bone material obtained in the comparative example was used to fill a bone defect in the mandible of a rabbit in the same manner as in the application example, the material adhered to the skin wound surface and suture closure was difficult. It was hot. In addition, even after suturing, dehiscence of the wound surface and reactive inflammation of the tissue were observed, and healing was delayed.

また、12週後及び24週後の骨組識の変化を顕微
鏡により観察したところ以下の知見を得た。
In addition, changes in bone structure after 12 and 24 weeks were observed using a microscope, and the following findings were obtained.

すなわち、12週後においても嵌植部位周辺の組
識の反応性炎症は続き、母床骨の周辺の粒子は新
生骨と結合しているが、大部分は、線維性結合組
識により取り囲まれていた。
In other words, even after 12 weeks, reactive inflammation in the tissue around the implantation site continues, and particles around the host bone are still connected to the new bone, but most of them are surrounded by fibrous connective tissue. was.

また、24週後においては、嵌植部位周辺の組識
の反応性炎症は、消えたが新生骨の生成は母床骨
の周辺に限定され、大部分の粒子は線維性結合組
識にり取り囲まれ、完全な骨生治瘉は得られなか
つた。
Furthermore, after 24 weeks, the reactive inflammation in the tissue around the implantation site had disappeared, but the generation of new bone was limited to the surroundings of the host bone, and most of the particles were transferred to the fibrous connective tissue. The bone was surrounded and complete bone healing could not be achieved.

Claims (1)

【特許請求の範囲】[Claims] 1 平均粒径0.1〜10μmの水酸アパタイト粉末
100重量部と、平均粒径10〜100μmの結晶セルロ
ース25〜100重量部との混合物を粒径0.1〜3.0mm
の顆粒に造粒したのち、900〜1400℃で焼成する
ことを特徴とする人工骨材料の製造方法。
1 Hydroxyapatite powder with an average particle size of 0.1 to 10 μm
A mixture of 100 parts by weight and 25 to 100 parts by weight of crystalline cellulose with an average particle size of 10 to 100 μm is mixed with a particle size of 0.1 to 3.0 mm.
A method for producing an artificial bone material, which comprises granulating the material into granules and then firing at 900 to 1400°C.
JP62266204A 1987-10-23 1987-10-23 Preparation of artificial bone material Granted JPS63294864A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62266204A JPS63294864A (en) 1987-10-23 1987-10-23 Preparation of artificial bone material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62266204A JPS63294864A (en) 1987-10-23 1987-10-23 Preparation of artificial bone material

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP59200131A Division JPS6179464A (en) 1984-09-25 1984-09-25 Composition for artificial bone material

Publications (2)

Publication Number Publication Date
JPS63294864A JPS63294864A (en) 1988-12-01
JPH0325181B2 true JPH0325181B2 (en) 1991-04-05

Family

ID=17427708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62266204A Granted JPS63294864A (en) 1987-10-23 1987-10-23 Preparation of artificial bone material

Country Status (1)

Country Link
JP (1) JPS63294864A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03191963A (en) * 1989-12-22 1991-08-21 Mitsubishi Materials Corp Calcium phosphate porous bone filter
JPH0440961A (en) * 1990-06-06 1992-02-12 Mitsubishi Materials Corp Filler for bone omission part, bone cavity part, and bone absorption part
JP2008173238A (en) * 2007-01-17 2008-07-31 Olympus Terumo Biomaterials Corp Manufacturing method of biological tissue filling material
EP3338815A1 (en) * 2016-12-23 2018-06-27 Sunstar Suisse SA Bone graft substitute

Also Published As

Publication number Publication date
JPS63294864A (en) 1988-12-01

Similar Documents

Publication Publication Date Title
Costantino et al. Hydroxyapatite cement: I. Basic chemistry and histologic properties
US6287341B1 (en) Orthopedic and dental ceramic implants
CA2270185C (en) Method of preparing a poorly crystalline calcium phosphate and methods of its use
US5783217A (en) Low temperature calcium phosphate apatite and a method of its manufacture
US6953594B2 (en) Method of preparing a poorly crystalline calcium phosphate and methods of its use
US7517539B1 (en) Method of preparing a poorly crystalline calcium phosphate and methods of its use
JP4260880B2 (en) Bone substitute material and method for producing the same
JP3035316B2 (en) Coated biological material and method for producing the biological material
JP2003506193A (en) Composite molded body and method for producing and using the same
JPS6343106B2 (en)
JPH0156777B2 (en)
JPS6330020B2 (en)
US20020136696A1 (en) Orthopedic and dental ceramic implants
WO2011068451A2 (en) Ceramic component for bone regeneration
CN100591365C (en) Inorganic resorbable bone substitute material
CN111773432A (en) Magnesium-based amorphous-calcium phosphate/calcium silicate composite filler and its preparation and application
JPH0411215B2 (en)
JP2005531339A (en) Tissue-engineered orthopedic scaffold
KR100579155B1 (en) Dental Metal Implants Coated with Calcium Metaphosphate and Manufacturing Method Thereof
JPH0325181B2 (en)
JP4802317B2 (en) Calcium phosphate ceramic bead assembly and method for constructing the same
Garcés-Villalá et al. Evaluation of two highly porous microcrystalline biphasic calcium phosphate-based bone grafts for bone regeneration: an experimental study in rabbits
JPH0575427B2 (en)
JPS6179463A (en) Composite apatite artificial bone material
KR102837982B1 (en) Porous inorganic material containing witrockite and hydroxyapatite, bone graft material containing the same, and manufacturing method thereof